- 米国企業
- scPharmaceuticals Inc.
scPharmaceuticals Inc.SCPH
時価総額
$1.7億
PER
2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | |
Research and development | 16 | 25 | 18 | 16 | 16 |
General and administrative | 14 | 8 | 12 | 10 | 21 |
Total operating expenses | 30 | 33 | 30 | 26 | 36 |
Loss from operations | -30 | -33 | -30 | -26 | -36 |
Other income | -0 | 0 | -0 | 0 | 1 |
Interest income | 2 | 2 | 0 | 0 | 1 |
Interest expense | 1 | 2 | 3 | 3 | 3 |
Net loss | -29 | -33 | -32 | -28 | -37 |
Net loss per share, basic | - | - | - | - | -1.3 |
Net loss per share, diluted | - | - | - | - | -1.3 |
Unrealized (loss) gain on short-term investments | - | - | 0 | -0 | 0 |
Comprehensive loss | - | - | -32 | -28 | -37 |